(Q43126990)

14 November 2017

0 references

Will the new antipsychotics improve the treatment of schizophrenia? (English)

1 reference

14 November 2017

1 reference

Hale T

1

1 reference

PMC publication ID

1696416

14 November 2017

language of work or name

English

0 references

publication date

1 September 1993

1 reference

14 November 2017

1 reference

14 November 2017

307

1 reference

14 November 2017

6907

1 reference

14 November 2017

749-750

1 reference

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability

14 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1696416

Invitation to compliance. The Prolixin brunch.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1696416

Why must some schizophrenic patients be involuntarily committed? The role of insight

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1696416

Drug-use evaluation programs for psychotropic medications.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1696416

25 May 2018

Insight and psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1696416

Housing instability and homelessness among rural schizophrenic patients

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1696416

From noncompliance to collaboration in the treatment of schizophrenia

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1696416

Psychological effects of previous treatment experiences with neuroleptics

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1696416

Fluphenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics. I. Relapse rates after one year

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1696416

Drug prescribing for schizophrenic out-patients on depot injections. Repeat surveys over 18 years

25 May 2018

1 reference

12 December 2020

Medication compliance and substance abuse among schizophrenic patients

1 reference

12 December 2020

A two-year prospective study of treatment compliance in patients with schizophrenia

1 reference

12 December 2020

[Prophylactic efficacy of long-acting vs. short-acting neuroleptics in schizophrenic out-patients (author's transl)]

1 reference

12 December 2020

Depot neuroleptics: the relevance of psychosocial factors--a United States perspective

1 reference

12 December 2020

Clinical characteristics, health beliefs and compliance with maintenance treatment: a comparison between regular and irregular attenders at a depot clinic

1 reference

12 December 2020

Self-reported neuroendocrine effects of antipsychotics in women: a pilot study

1 reference

12 December 2020

Surreptitious noncompliance with oral fluphenazine in a voluntary inpatient population

1 reference

12 December 2020

10.1136/BMJ.307.6907.749-A

Identifiers

DOI

1 reference

14 November 2017

1 reference

PMC publication ID

1696416

14 November 2017

PubMed publication ID

8106051

1 reference

PMC publication ID

1696416